Business Context and Reporting Period
Scilex Holding Company (SCLX) filed a Form 8-K Current Report on July 18, 2026. The filing discloses the entry into a Material Definitive Agreement and the completion of an asset disposition involving the sale of previously acquired preferred stock in Vivasor Holding Company.
Key Financial Metrics
This filing does not report standard operating financial metrics such as revenue, profit, cash flow, margins, or debt levels. The primary financial data point disclosed is the aggregate purchase price of $11,999,762.28 for the sale of Vivasor preferred stock.
| Transaction Component | Details |
|---|---|
| Asset Sold | 6,101,468 shares of Vivasor Series A-1 Preferred Stock and 355,919 shares of Vivasor Series A-2 Preferred Stock |
| Total Purchase Price | $11,999,762.28 |
| Payment Methods | Wire transfer, assignment of Datavault AI, Inc. common stock, or a combination thereof |
Material Changes and Transaction Structure
The Company agreed to sell the "Subject Shares" (acquired in January 2026) back to Vivasor Holding Company. The transaction is structured with payments in tranches over a period extending to mid-2027:
- Tranche 1: $999,980.97 paid on July 18, 2026.
- Tranche 2: $4,999,901.10 due on or before September 30, 2026.
- Tranche 3: $1,999,960.07 due on or before December 31, 2026.
- Tranche 4: $1,999,960.07 due on or before March 31, 2027.
- Tranche 5: $1,999,960.07 due on or before June 30, 2027.
Management Commentary, Risks, and Related Parties
Related Party Transaction: Dr. Henry Ji, Ph.D., serves as the Chief Executive Officer, President, and Chairperson of Scilex Holding Company and simultaneously serves as the Chief Executive Officer of Vivasor Holding Company.
Contingencies: The agreement includes customary representations, warranties, covenants, and indemnification provisions. The filing does not provide specific details on unusual items or forward-looking guidance beyond the payment schedule.
Investor Verification Checklist
- Verify the valuation and liquidity of the Datavault AI, Inc. common stock potentially used as payment.
- Review the full text of the Stock Repurchase Agreement (Exhibit 10.1) for specific covenants and indemnification terms.
- Confirm the impact of this transaction on the Company's consolidated financial statements, specifically regarding the recognition of gain or loss on the sale of the Vivasor preferred stock.
- Monitor the execution of the remaining four payment tranches through June 2027.